1. Home
  2. TNGX vs CHCO Comparison

TNGX vs CHCO Comparison

Compare TNGX & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$12.51

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo City Holding Company

CHCO

City Holding Company

HOLD

Current Price

$127.84

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNGX
CHCO
Founded
2014
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TNGX
CHCO
Price
$12.51
$127.84
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$13.00
$132.50
AVG Volume (30 Days)
3.1M
83.1K
Earning Date
02-26-2026
01-21-2026
Dividend Yield
N/A
2.73%
EPS Growth
N/A
13.18
EPS
N/A
8.93
Revenue
$66,501,000.00
$315,568,000.00
Revenue This Year
$52.80
$4.87
Revenue Next Year
N/A
$3.18
P/E Ratio
N/A
$14.27
Revenue Growth
53.29
8.16
52 Week Low
$1.03
$102.22
52 Week High
$13.46
$133.59

Technical Indicators

Market Signals
Indicator
TNGX
CHCO
Relative Strength Index (RSI) 62.52 65.32
Support Level $11.69 $119.59
Resistance Level $12.96 $129.03
Average True Range (ATR) 0.78 2.72
MACD -0.01 0.67
Stochastic Oscillator 81.65 94.44

Price Performance

Historical Comparison
TNGX
CHCO

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: